These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 13033518)

  • 1. [Methodological and clinical studies on the isolated determination of coagulation factor VII and prothrombin].
    WITTE S; DIRNBERGER P
    Dtsch Arch Klin Med; 1952; 199(5-6):492-501. PubMed ID: 13033518
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems of blood coagulation. VI. Method for prothrombin determination].
    MARBET R; WINTERSTEIN A
    Helv Physiol Pharmacol Acta; 1953; 11(1):81-95. PubMed ID: 13060875
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of liver function by determination of factor V, factor VII and prothrombin; effects of synkavit and vitamin K1].
    FORELL MM; KOLLER F
    Munch Med Wochenschr; 1953 Apr; 95(15):433-7. PubMed ID: 13072403
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of phenylindanedione on the coagulation factors prothrombin, factor V and factor VII and the question of vitamin K resistance].
    PERLICK E
    Klin Wochenschr; 1953 Mar; 31(11-12):261-3. PubMed ID: 13070456
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the prothrombin-proconvertin determinations (Owren-Aas) with prothrombin-index obtained with the Larsen-Plum prothrombin time method.
    LUND E; GEILL T; SØNDERGAARD E; DAM H
    Scand J Clin Lab Invest; 1955; 7(1):69-74. PubMed ID: 14396286
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research on the interpretation of tests on the utilization or consumption of prothrombin, Ac-globulin and antihemophilic globulin].
    DE NICOLA P
    Prog Med (Napoli); 1953 Jul; 9(14):421-5. PubMed ID: 13088960
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of the relationship of concentrations of prothrombin, proconvertin, and proaccelerin to three methods for measuring prothrombin time.
    GONYEA LM; HJORT P; OWREN PA
    J Lab Clin Med; 1956 Oct; 48(4):624-33. PubMed ID: 13367602
    [No Abstract]   [Full Text] [Related]  

  • 8. Prothrombin and proconvertin in the newborn and during the first year of life.
    DYGGVE H
    Acta Paediatr (Stockh); 1958 May; 47(3):251-9. PubMed ID: 13532682
    [No Abstract]   [Full Text] [Related]  

  • 9. The blood coagulation mechanism with especial reference to the prothrombin-proconvertin contents of plasma during long-term ACTH or cortisone therapy.
    FISCHER F; LUND E
    Acta Med Scand; 1954; 149(3):179-85. PubMed ID: 13180225
    [No Abstract]   [Full Text] [Related]  

  • 10. [Factor VII and anticoagulant therapy].
    DE LAS HERAS M; HESSELVIK L; LINDEN L
    Acta Soc Med Ups; 1953; 58(1-2):94-9. PubMed ID: 13057656
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 12. PROTHROMBIN LEVELS DURING THE FIRST YEAR OF LIFE. OBSERVATIONS FOLLOWED BY THE SYNTHETIC SUBSTRATE (TAME) ASSAY OF NORMAL FULL-TERM INFANTS.
    GLUECK HI; SUTHERLAND J; GLESER G
    Am J Dis Child; 1964 Jun; 107():612-7. PubMed ID: 14133821
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analytical study on Quick test; determination of prothrombin, proconvertin, and proaccelerin].
    SOULIER JP; LARRIEU MJ
    Sang; 1952; 23(7):549-59. PubMed ID: 13004906
    [No Abstract]   [Full Text] [Related]  

  • 14. [Owren's method for quantitative prothrombin-proconvertin determination in control of anticoagulant therapy].
    LUND E
    Ugeskr Laeger; 1953 May; 115(21):801-5. PubMed ID: 13077997
    [No Abstract]   [Full Text] [Related]  

  • 15. Micromethod for quantitative determination of plasma prothrombin and proconvertin.
    DYGGVE H; LUND E
    Acta Med Scand; 1954; 150(3):207-14. PubMed ID: 13206681
    [No Abstract]   [Full Text] [Related]  

  • 16. Some biochemical and electrophoretic studies on purified prothrombin, factor VII (proconvertin) and factor X (Stuart).
    TISHKOFF GH; PECHET L; ALEXANDER B
    Blood; 1960 May; 15():778-90. PubMed ID: 13838500
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of a coagulation factor in gynecology].
    SAMUEL S; BELLOMI C
    Quad Clin Ostet Ginecol; 1955 Dec; 10(12):879-90. PubMed ID: 13336234
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification and physiological properties of factor VII from plasma and serum; separation from prothrombin.
    DUCKERT F; KOLLER F; MATTER M
    Proc Soc Exp Biol Med; 1953 Feb; 82(2):259-61. PubMed ID: 13037863
    [No Abstract]   [Full Text] [Related]  

  • 20. [The mechanism of formation of coagulating factors prothrombin and factor VII].
    LASCH HG; ROKA L
    Klin Wochenschr; 1954 May; 32(19-20):460-4. PubMed ID: 13164277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.